STUART THERAPEUTICS (STUART)

Stuart Therapeutics (Stuart) is a clinical stage biopharmaceutical company focused on the development of a unique precision tissue reparative platform for eye diseases called PolyCol. PolyCol is a family of synthesized polypeptide sequences that are specifically designed to repair damaged extracellular matrix (ECM) collagen triple helix structures. These structures play an important role in healthy tissues and are damaged in chronic disease inflammatory processes. Stuart was founded in 2018, and the company was founded to champion a new approach to the treatment of chronic diseases.

Also known as: Stuart, Stuart Therapeutics

Primary location: Stuart United States